UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Find out which gas rewards card is best with no fee. Get insights to help you choose the right card for savings.
22,605 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
AI disruption fears loom over software stocks. This article explains why Unity Software is likely to endure and even ...
Uber stock jumps after AI chatter linked to Nvidia sparks a rally as the company details a 2027 robotaxi rollout and ...
Zcash slid roughly 15% in 48 hours, pushing toward $230 as a classic reversal pattern took hold and market sentiment ...
A sharp 20% plunge in Circle tokens sparked by yield shifts under a new Clarity Act framework. This morning minute re...
What if a hidden obstacle stands between you and a successful investment journey? The great filter is a lens to spot ...
A key Senate markup on the CLARITY Act is slated for May 14, with a handful of Democrats deciding whether the bill ad...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
As inflation runs hot and rate prospects swing, retail investors nod to inflation-defensive plays. Smithfield Foods a...
Mortgage lenders are shifting from deal-by-deal momentum to long-term advisory relationships, redefining growth in a ...
In just one year, Nebius Group has moved from curiosity to a marquee name in AI infrastructure. This piece unpacks wh...
June brings three key events that can move Disney stock. This guide explains the dates Disney stock investors should ...